Short Interest in BioNxt Solutions Inc. (OTCMKTS:BNXTF) Grows By 3,206.3%

BioNxt Solutions Inc. (OTCMKTS:BNXTF) saw a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 52,900 shares, a growth of 3,206.3% from the November 15th total of 1,600 shares. Based on an average trading volume of 52,700 shares, the short-interest ratio is presently 1.0 days.

BioNxt Solutions Price Performance

Shares of BioNxt Solutions stock traded down $0.02 on Wednesday, hitting $0.21. 770 shares of the company’s stock traded hands, compared to its average volume of 4,853. The firm’s 50-day moving average price is $0.19 and its two-hundred day moving average price is $0.20. The stock has a market capitalization of $23.50 million, a PE ratio of -5.18 and a beta of 0.84. BioNxt Solutions has a one year low of $0.11 and a one year high of $0.57.

BioNxt Solutions Company Profile

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.